The RAD51B and XRCC3 signatures can accurately discriminate MaBC from gynecomastia, with normal breast tissues showing methylation of these gene promoters at lower levels than in MaBC, suggesting the existence of a tumorigenesis pathway (3, 14). The gene discussed is XRCC3; the disease is Gynecomastia.